Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?

Author： Balar Arjun V.   Milowsky Matthew I.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|2|179-187

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.2, 2015-01, pp. : 179-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ellipticines as DNA-Targeted Chemotherapeutics

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-01 ,pp. : 575-591

Bentham Science Publishers

Access to resources Recommend Favorite

Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 263-274

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4218-4238

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review

By Blank Patricia R.  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 629-647

Adis International

Access to resources Recommend Favorite

Targeted therapy of hepatocellular cancer

By Wysocki Piotr Jan  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 265-274

Informa Healthcare

Access to resources Recommend Favorite